PITCHER (Peritoneal Carcinomatosis Heterogeneity)

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

How epigenetic deregulation affects gene expression patterns in subclones of the same tumor is poorly known. Peritoneal Carcinomatosis (PC) is a condition in which multiple metastases of the same abdominal tumor develop in the peritoneal cavity and intra-peritoneal organs, thus defining different ecosystems of the same cancer. PITCHER addresses the variations in epigenetically regulated gene expression between different subclones of PC in relation with cell mechanoresponses, providing insights on how cancer epigenetic landscapes evolve under environmental pressures and on strategies used by cancer cells to adapt to the transition from one ecosystem to the other. PITCHER is a network of 10 teams from Lyon, Grenoble and Marseille, based on data and specimen collection of patients who have undergone a surgery for a peritoneal carcinomatosis of ovarian or colorectal origin. PC lesions and eventually matched specimens of primary tumors will be collected in the same patients at the time of the surgery or eventually retrieved from already existing samples. Epigenetic landscapes will be analyzed by a bioinformatics pipeline combining exome sequencing, transcriptome and methylome to identify epigenetic hotspots, and their variations across lesions will be evaluated. These analyses will be realized in fresh (when available) or pre-existing samples. When possible, organoid cultures and animal models will be derived from multicellular structures in peritoneal fluids and membrane, cytoskeletal and nucleoskeletal mechanoresponses will be characterized using Atomic Force Microscopy. The role of tumor axonogenesis, a process of neo-formation of axon fibers in tumors, will be addressed. Experimental studies of cell responses to therapy will be performed to derive mathematical predictive models. All components will be integrated in a systems biology map of PC.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Patients who accept to participate to the study

• Men / women aged over 18 years

• Patients with cancer management and care for peritoneal carcinomatosis of digestive or ovarian origin

• Patients had histologic/radiologic confirmation of peritoneal disease

• Serology negative HIV, HEPATITIS

Locations
Other Locations
France
Lyon SUD Hospital, Hospices Civils de Lyon
RECRUITING
Lyon
Contact Information
Primary
Olivier GLEHEN, MD
olivier.glehen@chu-lyon.fr
+33 4 78 86 23 71
Backup
Sara CALATTINI, CRA
sara.calattini@chu-lyon.fr
+33 4 78 86 37 79
Time Frame
Start Date: 2020-09-01
Estimated Completion Date: 2027-09
Participants
Target number of participants: 20
Related Therapeutic Areas
Sponsors
Leads: Hospices Civils de Lyon

This content was sourced from clinicaltrials.gov